Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN112941114A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112941114A reveals high-purity enzymatic route for chiral triols. Reduces production cost and improves supply chain reliability for global pharmaceutical intermediates manufacturing.